Produktinformation
- (+)-Haloxyfop
- (2R)-2-(4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy)propanoic acid
- (2R)-2-[4-[[3-Chloro-5-(trifluoromethyl)-2-pyridinyl]oxy]phenoxy]propanoic acid
- (R)-(+)-Haloxyfop
- (R)-2-[4-[[3-Chloro-5-(trifluoromethyl)-2-pyridinyl]oxy]phenoxy]propanoic acid
- Haloxyfop-p-methyl TC
- Propanoic acid, 2-[4-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]oxy]phenoxy]-, (2R)-
- Propanoic acid, 2-[4-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]oxy]phenoxy]-, (R)-
Haloxyfop-P is a phosphatase inhibitor. It has been shown to inhibit the activity of human serum phosphatases, and can be used to prevent the activation of the immune system in tissue culture. Haloxyfop-P has also been shown to have an antibody response in monoclonal antibodies that are produced against viruses and monoclonal antibodies that are produced against fatty acids. Haloxyfop-P is being studied as a potential treatment for autoimmune diseases such as lupus and rheumatoid arthritis.